Skip to main content

Scientists Discover Way to Send Information into Black Holes Without Using Energy

3 comments

First Gene Therapy Approved to Restore Hearing in Children with Genetic Deafness

A major milestone in medical science has been reached in the United States. Health officials have approved a first-of-its-kind gene therapy designed to treat a rare form of hereditary hearing loss. This groundbreaking development could open the door to new treatments for many other types of hearing impairments in the future.

For the first time, scientists are not just managing hearing loss—they are trying to correct its root genetic cause.

A New Hope for Genetic Hearing Loss

In the United States, around 2 to 3 out of every 1,000 children are born with some form of hearing impairment. Even more concerning is that more than half of early-onset hearing loss cases are linked to genetic mutations.

This means that many children are born unable to hear properly due to changes in their DNA, not because of injury or illness after birth.

The newly approved treatment targets a very rare condition that affects about 50 newborns each year in the US. It focuses on mutations in a gene called OTOF, which is responsible for producing a protein essential for hearing. This protein helps transmit sound signals from the inner ear to the brain. When the gene does not work properly, the brain cannot receive sound information correctly, leading to severe hearing loss.

How the Treatment Works

The therapy, developed by the American biotechnology company Regeneron, is called Otarmeni.

Unlike traditional treatments such as hearing aids or cochlear implants, this approach works at the genetic level. Instead of amplifying sound, it aims to repair the faulty gene itself.

The treatment is given as a single injection directly into the inner ear by a surgeon. Once administered, it delivers a corrected version of the gene into the patient’s ear cells. These corrected cells can then begin producing the missing protein, allowing sound signals to be transmitted to the brain naturally.

Doctors describe this approach as revolutionary because it attempts to restore normal hearing rather than compensate for its loss.

Life-Changing Results in Clinical Trials

Before approval, the therapy was tested in clinical trials involving 20 children between the ages of 10 months and 16 years who had severe hearing loss.

The results were highly encouraging. At least 80% of the participants showed significant improvement in hearing within a few months of receiving the treatment.

Some children who had never responded to sound before began reacting to voices, music, and environmental noises for the first time in their lives.

Doctors involved in the study described emotional moments when children responded to their parents’ voices after treatment.

One of the lead researchers, Dr. Eliot Shearer from Boston Children’s Hospital, shared that witnessing these responses was deeply moving. He explained that the therapy represents a major shift in medicine because it can potentially restore “24/7 natural hearing,” something previously thought impossible for genetic hearing loss.

Emotional Impact on Families

For families, the treatment has brought hope and emotional relief.

At a White House event celebrating the development, Sierra Smith, the mother of a young boy named Travis who received the therapy, shared her experience.

She described how her child was once unable to respond to his name or recognize her voice. After treatment, everything changed. He began responding to sounds, enjoying music, and even dancing.

Her emotional words reflected what many parents feel:

Her child was no longer living in silence.

Stories like this highlight not only the medical success but also the human impact of the therapy. For many families, hearing loss can create communication barriers that affect emotional bonding, learning, and social development. Restoring hearing at an early age can significantly improve a child’s quality of life.

A New Era in Genetic Medicine

The US Food and Drug Administration (FDA) granted accelerated approval for the therapy, signaling confidence in its safety and effectiveness. Experts believe this decision marks the beginning of a new era in treating genetic disorders.

Dr. Shearer called it a turning point in medical science, explaining that this is one of the first times doctors can directly address the genetic cause of deafness instead of relying only on assistive devices.

This development also shows how far gene therapy has come in recent years. Once considered experimental and risky, gene-based treatments are now becoming real clinical solutions for complex diseases.

Challenges and Cost Concerns

Despite the excitement, gene therapies are known for being extremely expensive. In the United States, such treatments can cost millions of dollars per patient.

However, Regeneron has announced that it plans to offer this therapy free of charge to eligible US patients, which is a significant step toward making advanced genetic medicine more accessible.

Still, challenges remain. Scientists will need to monitor patients over many years to ensure the treatment remains safe and effective in the long term. There are also questions about whether similar therapies can be developed for more common forms of hearing loss.

What This Means for the Future

This approval is not just about one rare condition—it could change how doctors think about treating hearing loss in general.

If gene therapy continues to succeed, it may one day be used to treat a wide range of inherited hearing disorders. Researchers are already exploring similar approaches for other genes linked to deafness.

Beyond hearing loss, this success adds momentum to the broader field of genetic medicine, which aims to correct diseases at their biological root rather than just treating symptoms.

Conditions such as certain types of blindness, muscular disorders, and blood diseases are already being targeted by gene therapies under development.

Conclusion

The approval of this first-of-its-kind gene therapy marks a historic moment in medicine. For the first time, children born with a specific form of genetic hearing loss may have the chance to experience natural hearing.

While the treatment currently applies to a small group of patients, its impact is enormous. It represents hope—not just for those affected by hearing loss, but for the future of genetic medicine as a whole.

What was once considered science fiction is now becoming reality: the ability to repair faulty genes and restore lost senses.

As research continues, this breakthrough may be remembered as the beginning of a new era where silence caused by genetics can finally be reversed.

Comments

Post a Comment

Popular

Scientists Discover Way to Send Information into Black Holes Without Using Energy

For years, scientists believed that adding even one qubit (a unit of quantum information) to a black hole needed energy. This was based on the idea that a black hole’s entropy must increase with more information, which means it must gain energy. But a new study by Jonah Kudler-Flam and Geoff Penington changes that thinking. They found that quantum information can be teleported into a black hole without adding energy or increasing entropy . This works through a process called black hole decoherence , where “soft” radiation — very low-energy signals — carry information into the black hole. In their method, the qubit enters the black hole while a new pair of entangled particles (like Hawking radiation) is created. This keeps the total information balanced, so there's no violation of the laws of physics. The energy cost only shows up when information is erased from the outside — these are called zerobits . According to Landauer’s principle, erasing information always needs energy. But ...
3 comments
Read more

Black Holes That Never Dies

Black holes are powerful objects in space with gravity so strong that nothing can escape them. In the 1970s, Stephen Hawking showed that black holes can slowly lose energy by giving off tiny particles. This process is called Hawking radiation . Over time, the black hole gets smaller and hotter, and in the end, it disappears completely. But new research by Menezes and his team shows something different. Using a theory called Loop Quantum Gravity (LQG) , they studied black holes with quantum corrections. In their model, the black hole does not vanish completely. Instead, it stops shrinking when it reaches a very small size. This leftover is called a black hole remnant . They also studied something called grey-body factors , which affect how much energy escapes from a black hole. Their findings show that the black hole cools down and stops losing mass once it reaches a minimum mass . This new model removes the idea of a “singularity” at the center of the black hole and gives us a better ...
Post a Comment
Read more

How Planetary Movements Might Explain Sunspot Cycles and Solar Phenomena

Sunspots, dark patches on the Sun's surface, follow a cycle of increasing and decreasing activity every 11 years. For years, scientists have relied on the dynamo model to explain this cycle. According to this model, the Sun's magnetic field is generated by the movement of plasma and the Sun's rotation. However, this model does not fully explain why the sunspot cycle is sometimes unpredictable. Lauri Jetsu, a researcher, has proposed a new approach. Jetsu’s analysis, using a method called the Discrete Chi-square Method (DCM), suggests that planetary movements, especially those of Earth, Jupiter, and Mercury, play a key role in driving the sunspot cycle. His theory focuses on Flux Transfer Events (FTEs), where the magnetic fields of these planets interact with the Sun’s magnetic field. These interactions could create the sunspots and explain other solar phenomena like the Sun’s magnetic polarity reversing every 11 years. The Sun, our closest star, has been a subject of scient...
Post a Comment
Read more